The point of care diagnostics market size has grown strongly in recent years. It will grow from $48.06 billion in 2024 to $51.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise of chronic diseases, diagnostic accuracy improvements, shift in healthcare setting, healthcare cost pressures, consumer demand for convenience.
The point of care diagnostics market size is expected to see strong growth in the next few years. It will grow to $74.15 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to remote healthcare needs, market expansion in emerging economies, personalized healthcare, focus on preventive healthcare, investment in research & development. Major trends in the forecast period include rise of personalized medicine, technological miniaturization, telemedicine integration, emergence of novel biomarkers, consumer empowerment.
The rising incidence of chronic and infectious diseases is propelling the point-of-care (POC) diagnostics market. Chronic diseases are conditions that develop gradually over time and typically last three months or longer. POC diagnostics play a crucial role in the effective management of chronic diseases and are widely utilized due to their convenience. For example, in 2023, the Centers for Disease Control and Prevention (CDC) reported that 42% of adults in the U.S. were living with two or more chronic conditions. This trend raises concerns as it underscores the increasing prevalence of multiple chronic diseases among the adult population. Consequently, the growing prevalence of chronic diseases is driving the expansion of the point-of-care (POC) diagnostics market.
The point-of-care (POC) diagnostics market is set to experience growth propelled by the rising demand for at-home testing. At-home testing involves self-sample collection and testing using over-the-counter or online kits/devices. Point-of-care (POC) diagnostics play a pivotal role in at-home testing, allowing individuals to conveniently monitor their health status. A survey conducted in December 2022 revealed that approximately 25% of consumers demand at-home testing, with 21% finding it convenient. This increasing preference for at-home testing is a significant contributor to the expanding point-of-care (POC) diagnostics market.
Innovation is a prominent trend in the point-of-care (POC) diagnostics market, with major companies introducing novel products to maintain their market position. For instance, PocDoc, a US-based diagnostics company, launched the PocDoc Cardiovascular Diseases point-of-care test in January 2022. This innovative product stands out as the world's first smartphone-based test for cardiovascular disease, offering users a five-step process, including sample collection, lateral flow test kit usage, and instant diagnosis on their smartphones.
Key players in the point-of-care (POC) diagnostics market are concentrating on technological innovations, such as rapid PCR systems, to secure a competitive advantage. A rapid PCR system is a type of polymerase chain reaction (PCR) test that delivers results faster than traditional PCR tests. For example, in January 2023, Cipla, a pharmaceutical company based in India, introduced its point-of-care testing device named Cippoint. This innovative device is designed to provide quick and accurate diagnostic results for a variety of health conditions. The Cippoint platform is compact, user-friendly, and adaptable for use in various settings, including hospitals and clinics. It utilizes advanced technology that allows healthcare professionals to conduct tests efficiently and effectively.
In July 2024, Roche, a pharmaceutical company based in Switzerland, acquired LumiraDx's point-of-care technology for an undisclosed sum. This strategic acquisition is intended to improve Roche's access to diagnostic testing in primary care environments. LumiraDx, a company located in the U.S., specializes in innovative point-of-care diagnostic solutions.
Major companies operating in the point of care diagnostics market include Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter Inc., Becton, Dickinson and Company, Instrumentation Laboratory Company, Nova Biomedical Corporation, Qiagen NV, F. Hoffmann-La Roche Ltd., Biomeriux SA, Quidel Corporation, Orasure Technologies Inc., Johnson and Johnson, Thermo Fisher Scientific Inc., Sysmex corporation, Sinocare Inc., Arkray Inc., Danaher Corporation, Chembio Diagnostics Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Fluxergy Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., Nipro Europe Group Companies, AccuBioTech Co. Ltd., Atlas Genetics Ltd., Atlas Link Biotech Co. Ltd., Biomeme Inc., Cepheid Inc., Church & Dwight Co. Inc.
North America was the largest region in the point of care diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the point of care diagnostics market report during the forecast period. The regions covered in the point of care diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Point of care (POC) diagnostics involves medical testing conducted at or near the location of patient care, providing fast and accurate results to guide immediate patient care decisions.
The primary product types in point of care diagnostics include glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, cholesterol test strips, and others. Glucose monitoring kits are medical devices designed to measure the levels of glucose (sugar) in a person's blood. They are available as both over-the-counter (OTC) devices and prescription-based devices, catering to various end-users such as professional diagnostic centers, research laboratories, home care settings, and others.
The point of care diagnostics market research report is one of a series of new reports that provides point of care diagnostics optical components market statistics, including point of care diagnostics optical components industry global market size, regional shares, competitors with a point of care diagnostics optical components market share, detailed point of care diagnostics optical components market segments, market trends and opportunities, and any further data you may need to thrive in the point of care diagnostics optical components industry. This point of care diagnostics optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The point of care (POC) diagnostics market consists of sales of blood glucose meters, pregnancy test kits, and cardiac markers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The point of care diagnostics market size is expected to see strong growth in the next few years. It will grow to $74.15 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to remote healthcare needs, market expansion in emerging economies, personalized healthcare, focus on preventive healthcare, investment in research & development. Major trends in the forecast period include rise of personalized medicine, technological miniaturization, telemedicine integration, emergence of novel biomarkers, consumer empowerment.
The rising incidence of chronic and infectious diseases is propelling the point-of-care (POC) diagnostics market. Chronic diseases are conditions that develop gradually over time and typically last three months or longer. POC diagnostics play a crucial role in the effective management of chronic diseases and are widely utilized due to their convenience. For example, in 2023, the Centers for Disease Control and Prevention (CDC) reported that 42% of adults in the U.S. were living with two or more chronic conditions. This trend raises concerns as it underscores the increasing prevalence of multiple chronic diseases among the adult population. Consequently, the growing prevalence of chronic diseases is driving the expansion of the point-of-care (POC) diagnostics market.
The point-of-care (POC) diagnostics market is set to experience growth propelled by the rising demand for at-home testing. At-home testing involves self-sample collection and testing using over-the-counter or online kits/devices. Point-of-care (POC) diagnostics play a pivotal role in at-home testing, allowing individuals to conveniently monitor their health status. A survey conducted in December 2022 revealed that approximately 25% of consumers demand at-home testing, with 21% finding it convenient. This increasing preference for at-home testing is a significant contributor to the expanding point-of-care (POC) diagnostics market.
Innovation is a prominent trend in the point-of-care (POC) diagnostics market, with major companies introducing novel products to maintain their market position. For instance, PocDoc, a US-based diagnostics company, launched the PocDoc Cardiovascular Diseases point-of-care test in January 2022. This innovative product stands out as the world's first smartphone-based test for cardiovascular disease, offering users a five-step process, including sample collection, lateral flow test kit usage, and instant diagnosis on their smartphones.
Key players in the point-of-care (POC) diagnostics market are concentrating on technological innovations, such as rapid PCR systems, to secure a competitive advantage. A rapid PCR system is a type of polymerase chain reaction (PCR) test that delivers results faster than traditional PCR tests. For example, in January 2023, Cipla, a pharmaceutical company based in India, introduced its point-of-care testing device named Cippoint. This innovative device is designed to provide quick and accurate diagnostic results for a variety of health conditions. The Cippoint platform is compact, user-friendly, and adaptable for use in various settings, including hospitals and clinics. It utilizes advanced technology that allows healthcare professionals to conduct tests efficiently and effectively.
In July 2024, Roche, a pharmaceutical company based in Switzerland, acquired LumiraDx's point-of-care technology for an undisclosed sum. This strategic acquisition is intended to improve Roche's access to diagnostic testing in primary care environments. LumiraDx, a company located in the U.S., specializes in innovative point-of-care diagnostic solutions.
Major companies operating in the point of care diagnostics market include Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter Inc., Becton, Dickinson and Company, Instrumentation Laboratory Company, Nova Biomedical Corporation, Qiagen NV, F. Hoffmann-La Roche Ltd., Biomeriux SA, Quidel Corporation, Orasure Technologies Inc., Johnson and Johnson, Thermo Fisher Scientific Inc., Sysmex corporation, Sinocare Inc., Arkray Inc., Danaher Corporation, Chembio Diagnostics Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Fluxergy Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., Nipro Europe Group Companies, AccuBioTech Co. Ltd., Atlas Genetics Ltd., Atlas Link Biotech Co. Ltd., Biomeme Inc., Cepheid Inc., Church & Dwight Co. Inc.
North America was the largest region in the point of care diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the point of care diagnostics market report during the forecast period. The regions covered in the point of care diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Point of care (POC) diagnostics involves medical testing conducted at or near the location of patient care, providing fast and accurate results to guide immediate patient care decisions.
The primary product types in point of care diagnostics include glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, cholesterol test strips, and others. Glucose monitoring kits are medical devices designed to measure the levels of glucose (sugar) in a person's blood. They are available as both over-the-counter (OTC) devices and prescription-based devices, catering to various end-users such as professional diagnostic centers, research laboratories, home care settings, and others.
The point of care diagnostics market research report is one of a series of new reports that provides point of care diagnostics optical components market statistics, including point of care diagnostics optical components industry global market size, regional shares, competitors with a point of care diagnostics optical components market share, detailed point of care diagnostics optical components market segments, market trends and opportunities, and any further data you may need to thrive in the point of care diagnostics optical components industry. This point of care diagnostics optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The point of care (POC) diagnostics market consists of sales of blood glucose meters, pregnancy test kits, and cardiac markers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Point of Care Diagnostics Market Characteristics3. Point of Care Diagnostics Market Trends and Strategies4. Point of Care Diagnostics Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Point of Care Diagnostics Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Point of Care Diagnostics Market34. Recent Developments in the Point of Care Diagnostics Market
5. Global Point of Care Diagnostics Growth Analysis and Strategic Analysis Framework
6. Point of Care Diagnostics Market Segmentation
7. Point of Care Diagnostics Market Regional and Country Analysis
8. Asia-Pacific Point of Care Diagnostics Market
9. China Point of Care Diagnostics Market
10. India Point of Care Diagnostics Market
11. Japan Point of Care Diagnostics Market
12. Australia Point of Care Diagnostics Market
13. Indonesia Point of Care Diagnostics Market
14. South Korea Point of Care Diagnostics Market
15. Western Europe Point of Care Diagnostics Market
16. UK Point of Care Diagnostics Market
17. Germany Point of Care Diagnostics Market
18. France Point of Care Diagnostics Market
19. Italy Point of Care Diagnostics Market
20. Spain Point of Care Diagnostics Market
21. Eastern Europe Point of Care Diagnostics Market
22. Russia Point of Care Diagnostics Market
23. North America Point of Care Diagnostics Market
24. USA Point of Care Diagnostics Market
25. Canada Point of Care Diagnostics Market
26. South America Point of Care Diagnostics Market
27. Brazil Point of Care Diagnostics Market
28. Middle East Point of Care Diagnostics Market
29. Africa Point of Care Diagnostics Market
30. Point of Care Diagnostics Market Competitive Landscape and Company Profiles
31. Point of Care Diagnostics Market Other Major and Innovative Companies
35. Point of Care Diagnostics Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Point of Care Diagnostics Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on point of care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for point of care diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point of care diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Glucose Monitoring Kits; Infectious Diseases Testing Kits; Pregnancy and Fertility Testing Kits; Hematology Testing Kits; Cardiometabolic Monitoring Kits; Urinalysis Testing Kits; Cholesterol Test Strips; Other Products2) by Mode of Prescription: Prescription Based Devices; OTC (Over-the-Counter) Based Devices
3) by End User: Professional Diagnostic Centers; Research Laboratories; Home Care; Other End-Users
Subsegments:
1) by Glucose Monitoring Kits: Blood Glucose Meters; Test Strips2) by Infectious Diseases Testing Kits: Rapid Antigen Tests; PCR Testing Kits; Serology Tests
3) by Pregnancy and Fertility Testing Kits: Home Pregnancy Tests; Ovulation Predictor Kits
4) by Hematology Testing Kits: Complete Blood Count (CBC) Test Kits; Coagulation Test Kits
5) by Cardiometabolic Monitoring Kits: Lipid Profile Test Kits; Blood Pressure Monitors
6) by Urinalysis Testing Kits: Dipstick Test Kits; Urine Culture Kits
7) by Cholesterol Test Strips: Home Cholesterol Testing Kits
8) by Other Products: Customizable Test Kits; Point of Care Testing Platforms
Key Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; Beckman Coulter Inc.; Becton, Dickinson and Company; Instrumentation Laboratory Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Point of Care Diagnostics market report include:- Abbott Laboratories
- Siemens Healthineers AG
- Beckman Coulter Inc.
- Becton, Dickinson and Company
- Instrumentation Laboratory Company
- Nova Biomedical Corporation
- Qiagen NV
- F. Hoffmann-La Roche Ltd.
- Biomeriux SA
- Quidel Corporation
- Orasure Technologies Inc.
- Johnson and Johnson
- Thermo Fisher Scientific Inc.
- Sysmex corporation
- Sinocare Inc.
- Arkray Inc.
- Danaher Corporation
- Chembio Diagnostics Inc.
- EKF Diagnostics Holdings plc
- Trinity Biotech plc
- Fluxergy Inc.
- LumiraDx UK Ltd.
- Meridian Bioscience Inc.
- Nipro Europe Group Companies
- AccuBioTech Co. Ltd.
- Atlas Genetics Ltd.
- Atlas Link Biotech Co. Ltd.
- Biomeme Inc.
- Cepheid Inc.
- Church & Dwight Co. Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 51.76 Billion |
| Forecasted Market Value ( USD | $ 74.15 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
